June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Visual Correlation of OCT-Angiographic Features in Neovascular Age-Related Macular Degeneration
Author Affiliations & Notes
  • Kevin Elwood
    University of Wisconsin-Madison Department of Ophthalmology and Visual Sciences, Madison, Wisconsin, United States
  • Rachel E Linderman
    University of Wisconsin-Madison Department of Ophthalmology and Visual Sciences, Madison, Wisconsin, United States
  • Jeong W Pak
    University of Wisconsin-Madison Department of Ophthalmology and Visual Sciences, Madison, Wisconsin, United States
  • Rick Voland
    University of Wisconsin-Madison Department of Ophthalmology and Visual Sciences, Madison, Wisconsin, United States
  • Amitha Domalpally
    University of Wisconsin-Madison Department of Ophthalmology and Visual Sciences, Madison, Wisconsin, United States
  • Barbara A Blodi
    University of Wisconsin-Madison Department of Ophthalmology and Visual Sciences, Madison, Wisconsin, United States
  • Footnotes
    Commercial Relationships   Kevin Elwood None; Rachel Linderman None; Jeong Pak None; Rick Voland None; Amitha Domalpally None; Barbara Blodi None
  • Footnotes
    Support  Supported by Research to Prevent Blindness and a National Eye Institute Vision Research Core
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 287. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kevin Elwood, Rachel E Linderman, Jeong W Pak, Rick Voland, Amitha Domalpally, Barbara A Blodi; Visual Correlation of OCT-Angiographic Features in Neovascular Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2023;64(8):287.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : OCT-Angiography (OCTA) presents numerous features with uncertain clinical significance in neovascular age-related macular degeneration (NVAMD). We performed a retrospective, observational, cross-sectional, clinical study to identify potential associations between OCTA features and visual acuity (VA) in eyes treated for NVAMD.

Methods : Study population included patients with NVAMD in one or both eyes undergoing standard of care anti-VEGF treatment with OCTA Optovue scans available (43 patients, 67 eyes). Collected OCTA features included macular neovascularization (MNV) presence, MNV location, MNV type, MNV area, MNV flow area, flow density (flow area/MNV area), central vascular trunk presence, along with OCT features of macular atrophy, intraretinal and subretinal fluid (IRF, SRF), and central subfield thickness. Patient data included VA, age, sex, smoking status, days from treatment start to OCTA scan, number of anti-VEGF injections per study eye (if known), and presence of MNV in the fellow eye. Evaluation was performed at Wisconsin Reading Center by two graders with adjudication when needed. Statistical analysis consisted of univariate and multivariate regression of logMAR VA and OCTA/patient data features.

Results : Of the 57 gradable eyes (39 patients: mean age 78 years, 21 (60%) female), 32 (56%) had MNV visible on OCTA. MNV was at center point in 18 eyes (32%). Twenty eyes (35%) had MNV Type 1, 3 (5%) Type 2, 6 (11%) Mixed, 3 (6%) Indeterminate. There was an average MNV area of 3.41mm2, flow area of 2.04mm2, and flow density of 0.62. A central vascular trunk was present in 14 (25%), central IRF in 10 (18%), non-central IRF in 7 (12%), central SRF in 18 (32%), non-central SRF in 7 (12%), and macular atrophy in 3 (6%). Current VA negatively correlated with age (p=0.003), previous visit VA (p<0.001), MNV presence (p=0.039), and IRF presence (p<0.001) in univariate regression analysis. In multivariate analysis, VA negatively correlated with MNV presence (p=0.043), age (p=0.038), previous visit VA (p<0.001), and central IRF (p=0.012).

Conclusions : While presence of MNV on OCTA is an important feature associated with decreased VA in treated eyes, other individual features of MNV as assessed by OCTA have uncertain significance. Further research is needed to utilize OCTA features as measurement endpoints in clinical practice and studies.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

OCTA MNV example of subject 34

OCTA MNV example of subject 34

 

Table 1. Multivariate model

Table 1. Multivariate model

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×